샘플 요청 목록

 카트 문의
시장보고서
상품코드
1972869

주사 지방 분해 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)

Injection Lipolysis Market Insights, Competitive Landscape, and Market Forecast - 2033
발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 183 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

주사 지방 분해 시장은 비침습적 미용 시술에 대한 소비자의 관심 증가와 바디 컨투어링 솔루션에 대한 인지도 향상으로 향후 몇 년간 꾸준한 성장이 예상됩니다. 시장 규모는 2026년 13억 3,000만 달러로 추정되며, 2033년까지 18억 달러에 달할 것으로 예상되며, 이는 CAGR 4.3%를 반영합니다. 이러한 성장은 기존 수술적 대안에 비해 회복 기간이 단축되고 표적 지방을 감소시키는 최소침습적 치료로의 전환을 강조하고 있습니다.

시장 개요

주사 지방 분해는 약물 주사를 이용하여 국소적인 지방 침착을 타겟으로 하는 시술입니다. 지방세포를 분해하고 체내의 자연적인 대사 과정을 통해 배출을 촉진합니다. 가장 널리 사용되는 약제에는 지방 용해 작용으로 알려진 데옥시콜산과 포스파티딜콜린이 포함됩니다. 이 시술은 저침습성, 부작용이 적고 복부, 허벅지, 팔뚝, 상완, 턱밑 등 다양한 치료 부위에 대한 효과로 주목받고 있습니다. 약물 전달 기술의 혁신과 제형 개선으로 치료 효과가 더욱 향상되고 환자들의 신뢰와 채택률이 향상되고 있습니다.

주요 시장 성장 촉진요인

주사 지방 분해 시장의 성장을 견인하는 요인은 다음과 같습니다.

  • 1. 미용에 대한 인식 증가 - 소셜 미디어의 영향, 유명인의 추천, 외모에 대한 관심 증가는 침습적 수술 없이도 눈에 보이는 효과를 주는 미용 치료에 대한 수요를 촉진하고 있습니다.
  • 2. 비수술적 시술 선호 - 환자들은 통증 감소, 합병증 위험 감소, 회복 기간 단축 등의 이유로 지방흡입 및 기타 수술적 지방 감소 방법의 대안으로 비수술적 시술에 대한 선호도가 높아지고 있습니다.
  • 3. 미용클리닉 및 외래진료센터 확대 - 전문 피부과 및 미용시설 증가로 더 많은 분들이 지방용해주사 요법을 쉽게 받을 수 있게 되었습니다.
  • 4. 기술적 진보 - 보다 안전하고 효과적인 주사 기술과 약물의 지속적인 개발로 치료 효율과 환자 만족도가 향상되고 있습니다.
  • 5. 인구통계학적 동향 - 고령화되는 세계 인구에서 고질적인 지방 축적과 노화에 따른 체형 변화에 대한 해결책을 찾는 목소리가 높아지면서 더 많은 수요를 창출하고 있습니다.

새로운 기회

주사 지방 분해 시장은 기존 기업과 신규 진출기업 모두에게 많은 기회를 제공합니다. 새로운 지방 용해 화합물의 연구개발, 보다 안전한 제형, 첨단 전달 시스템을 위한 연구개발은 큰 경쟁 우위를 가져올 수 있습니다. 피부과-미용 클리닉과의 제휴 및 저침습적 시술을 강조한 타겟 마케팅 캠페인은 더욱 확산될 것입니다. 신흥 시장도 유망한 잠재력을 가지고 있으며, 가처분 소득 증가와 미용 시술에 대한 인지도 향상으로 새로운 소비자층이 생겨나고 있습니다.

주요 비즈니스 기회는 다음과 같습니다.

  • 더 높은 효과와 적은 부작용을 가진 차세대 주사제 개발.
  • 비수술적 바디 컨투어링 치료를 전문으로 하는 전문 시설 설립.
  • 디지털 마케팅과 소셜 미디어 플랫폼을 활용하여 주사 지방 분해의 장점에 대해 환자들에게 알리는 활동을 전개하는 것.
  • 웰니스 및 예방 의료 서비스 제공업체와의 제휴를 통해 미용 치료를 종합적인 건강 프로그램에 통합합니다.

지역별 인사이트

북미는 미용 시술에 대한 높은 인지도, 선진화된 의료 인프라, 혁신적인 치료법의 적극적인 도입으로 세계 주사 지방 용해 시장을 선도하고 있습니다. 미국은 주요 기업들이 조사, 마케팅, 유통망에 대한 투자를 지속하고 있는 가운데, 계속해서 중요한 기여 국가로 자리매김하고 있습니다.

유럽, 특히 독일, 프랑스, 영국 등의 국가에서는 저침습적 미용 솔루션에 대한 환자 수요와 안전성과 유효성을 보장하는 엄격한 규제 기준에 힘입어 큰 성장 잠재력을 가지고 있습니다.

아시아태평양은 가처분 소득 증가, 중산층 인구 증가, 비수술적 미용 시술에 대한 인식 개선 등을 배경으로 가장 빠른 성장이 예상됩니다. 중국, 인도, 한국이 이 지역의 주요 시장으로 부상하고 있습니다.

라틴아메리카 및 중동 및 아프리카에서는 주사 지방 분해가 점차 대중화되고 있습니다. 이 지역의 성장은 미용을 목적으로 한 해외여행 증가와 고급 바디 컨투어링 서비스를 제공하는 미용 및 피부과 클리닉 증가에 의해 뒷받침되고 있습니다.

경쟁 구도

세계 주사 지방 분해 시장은 경쟁이 치열하고, 다국적 기업과 지역 기업이 혼합되어 혁신을 촉진하고 사업 범위를 확장하고 있습니다. 이 시장에서 활동하는 주요 기업으로는 다음과 같은 기업들이 있습니다.

  • Allergan(AbbVie)
  • Cynosure(Hologic)
  • Galderma
  • Merz Aesthetics
  • SBC Aesthetic
  • Suneva Medical
  • Dermatech Corporation
  • Teoxane Laboratories
  • Biotech Pharma Group
  • Sculpture Aesthetic
  • Lumenis
  • BTL Aesthetics
  • InMode(Alma Lasers)
  • Cutera, Inc.
  • Revanesse(Prollenium Medical)

이들 기업은 시장 점유율을 확보하고 비침습적 지방 감소 치료에 대한 수요 증가에 대응하기 위해 제품 혁신, 전략적 제휴, 합병, 지리적 확장에 주력하고 있습니다.

시장 세분화

약제 유형별:

  • 데옥시콜산
  • 포스파티딜콜린
  • 기타

치료 부위별:

  • 얼굴 지방 침착
  • 턱밑지방
  • 상완 지방
  • 복부 지방
  • 허벅지 지방
  • 무릎 지방
  • 엉덩이 지방
  • 기타

최종 사용자별:

  • 병원
  • 피부과 및 미용 클리닉
  • 외래수술센터

지역별:

  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 밸류체인 분석
  • COVID-19의 영향 분석
  • Porter의 Five Forces 분석
  • 러시아·우크라이나 분쟁의 영향
  • PESTLE 분석
  • 규제 분석
  • 가격 동향 분석
    • 현재 가격과 향후 예측, 2025년-2033년
    • 가격 영향요인

제3장 세계의 주사 지방 분해 시장 전망, 2020년-2033년

  • 세계의 주사 지방 분해 시장 전망, 약제 유형별, 금액(10억 달러), 2020년-2033년
    • 데오키시코르산
    • 호스파치지르코린
    • 기타
  • 세계의 주사 지방 분해 시장 전망, 치료 부위별, 금액(10억 달러), 2020년-2033년
    • 얼굴 지방 침착
    • 악하 지방
    • 상완 지방
    • 복부 지방
    • 허벅지 지방
    • 무릎 지방
    • 엉덩이 지방
    • 기타
  • 세계의 주사 지방 분해 시장 전망, 최종사용자별, 금액(10억 달러), 2020년-2033년
    • 병원
    • 피부과 및 미용 클리닉
    • 외래수술센터(ASC)
  • 세계의 주사 지방 분해 시장 전망, 지역별, 금액(10억 달러), 2020년-2033년
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카

제4장 북미 주사 지방 분해 시장 전망, 2020년-2033년

제5장 유럽 주사 지방 분해 시장 전망, 2020년-2033년

제6장 아시아태평양 주사 지방 분해 시장 전망, 2020년-2033년

  • 아시아태평양 주사 지방 분해 시장 전망, 최종사용자별, 금액(10억 달러), 2020년-2033년

    제7장 라틴아메리카 주사 지방 분해 시장 전망, 2020년-2033년

    제8장 중동 및 아프리카 주사 지방 분해 시장 전망, 2020년-2033년

    제9장 경쟁 구도

    • 기업대 부문 히트맵
    • 기업의 시장 점유율 분석, 2025년
    • 경쟁 대시보드
    • 기업 개요
      • Allergan(AbbVie)
      • Cynosure(Hologic)
      • Galderma
      • Merz Aesthetics
      • SBC Aesthetic
      • Suneva Medical
      • Dermatech Corporation
      • Teoxane Laboratories
      • Biotech Pharma Group
      • Sculpture Aesthetic

    제10장 부록

    LSH

    The Injection Lipolysis Market is projected to experience steady growth over the coming years, driven by increasing consumer interest in non-invasive cosmetic procedures and heightened awareness of body contouring solutions. The market is estimated at USD 1.33 billion in 2026 and is expected to grow to USD 1.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.3%. This growth highlights the shift toward minimally invasive treatments that deliver targeted fat reduction with reduced recovery times compared to traditional surgical options.

    Market Overview

    Injection lipolysis is a procedure designed to target localized fat deposits using pharmaceutical injections, which break down fat cells for natural elimination by the body. The most widely used agents include deoxycholic acid and phosphatidylcholine, both known for their fat-dissolving properties. The procedure has gained traction due to its minimally invasive nature, limited side effects, and effectiveness across multiple treatment areas such as the abdomen, thighs, upper arms, and submental region. Innovations in drug delivery techniques and formulation improvements have further enhanced treatment outcomes, boosting patient confidence and adoption rates.

    Key Market Drivers

    Several factors are driving the expansion of the injection lipolysis market:

    • 1. Growing Aesthetic Awareness - Social media influence, celebrity endorsements, and rising interest in personal appearance have fueled demand for cosmetic treatments that provide visible results without invasive surgery.
    • 2. Preference for Non-Surgical Procedures - Patients increasingly seek alternatives to liposuction and other surgical fat reduction methods due to reduced pain, lower complication risks, and shorter recovery periods.
    • 3. Expansion of Cosmetic Clinics and Ambulatory Centers - The proliferation of specialized dermatology and cosmetic centers has made injection lipolysis more accessible to a wider population.
    • 4. Technological Advancements - Continuous development of safer and more effective injection techniques and formulations has improved treatment efficiency and patient satisfaction.
    • 5. Demographic Trends - The aging global population is increasingly seeking solutions for stubborn fat deposits and age-related body contour changes, creating additional demand.

    Emerging Opportunities

    The injection lipolysis market offers numerous opportunities for both established companies and new entrants. Research and development aimed at new fat-dissolving compounds, safer formulations, and advanced delivery systems can provide significant competitive advantages. Collaborations with dermatology and cosmetic clinics, along with targeted marketing campaigns emphasizing minimally invasive procedures, can further drive adoption. Emerging markets also offer promising potential, as growing disposable incomes and awareness of aesthetic procedures create new consumer bases.

    Key business opportunities include:

    • Development of next-generation injectable compounds with higher efficacy and fewer side effects.
    • Establishing specialized centers focused exclusively on non-surgical body contouring treatments.
    • Leveraging digital marketing and social media platforms to educate patients on the benefits of injection lipolysis.
    • Partnering with wellness and preventive healthcare providers to integrate cosmetic treatments into broader wellness programs.

    Regional Insights

    North America leads the global injection lipolysis market due to high awareness of aesthetic procedures, advanced healthcare infrastructure, and strong adoption of innovative treatment options. The United States remains a key contributor, with major players investing in research, marketing, and distribution networks.

    Europe shows significant growth potential, particularly in countries such as Germany, France, and the United Kingdom, driven by patient demand for minimally invasive cosmetic solutions and strict regulatory standards that ensure safety and efficacy.

    Asia Pacific is anticipated to register the fastest growth, fueled by increasing disposable income, growing middle-class populations, and rising awareness of non-surgical aesthetic procedures. China, India, and South Korea are emerging as key markets in this region.

    Latin America and the Middle East & Africa are gradually adopting injection lipolysis treatments. Growth in these regions is supported by rising aesthetic tourism and an increasing number of cosmetic and dermatology clinics offering advanced body contouring services.

    Competitive Landscape

    The global injection lipolysis market is competitive, with a mix of multinational corporations and regional players driving innovation and expanding reach. Key companies operating in this market include:

    • Allergan (AbbVie)
    • Cynosure (Hologic)
    • Galderma
    • Merz Aesthetics
    • SBC Aesthetic
    • Suneva Medical
    • Dermatech Corporation
    • Teoxane Laboratories
    • Biotech Pharma Group
    • Sculpture Aesthetic
    • Lumenis
    • BTL Aesthetics
    • InMode (Alma Lasers)
    • Cutera, Inc.
    • Revanesse (Prollenium Medical)

    These players focus on product innovation, strategic alliances, mergers, and geographic expansion to capture market share and meet the growing demand for non-invasive fat reduction treatments.

    Market Segmentation

    By Drug Type:

    • Deoxycholic Acid
    • Phosphatidylcholine
    • Others

    By Treatment Site:

    • Facial Fat Deposits
    • Submental Fat
    • Upper Arm Fat
    • Abdominal Fat
    • Thighs Fat
    • Knee Fat
    • Buttock Fat
    • Others

    By End-User:

    • Hospitals
    • Dermatology and Cosmetic Clinics
    • Ambulatory Surgical Centers

    By Region:

    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East and Africa

    Table of Contents

    1. Executive Summary

    • 1.1. Global Injection Lipolysis Market Snapshot
    • 1.2. Future Projections
    • 1.3. Key Market Trends
    • 1.4. Regional Snapshot, by Value, 2026
    • 1.5. Analyst Recommendations

    2. Market Overview

    • 2.1. Market Definitions and Segmentations
    • 2.2. Market Dynamics
      • 2.2.1. Drivers
      • 2.2.2. Restraints
      • 2.2.3. Market Opportunities
    • 2.3. Value Chain Analysis
    • 2.4. COVID-19 Impact Analysis
    • 2.5. Porter's Five Forces Analysis
    • 2.6. Impact of Russia-Ukraine Conflict
    • 2.7. PESTLE Analysis
    • 2.8. Regulatory Analysis
    • 2.9. Price Trend Analysis
      • 2.9.1. Current Prices and Future Projections, 2025-2033
      • 2.9.2. Price Impact Factors

    3. Global Injection Lipolysis Market Outlook, 2020-2033

    • 3.1. Global Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
      • 3.1.1. Deoxycholic Acid
      • 3.1.2. Phosphatidylcholine
      • 3.1.3. Others
    • 3.2. Global Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
      • 3.2.1. Facial Fat Deposits
      • 3.2.2. Submental Fat
      • 3.2.3. Upper Arm Fat
      • 3.2.4. Abdominal Fat
      • 3.2.5. Thighs Fat
      • 3.2.6. Knee Fat
      • 3.2.7. Buttock Fat
      • 3.2.8. Others
    • 3.3. Global Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
      • 3.3.1. Hospitals
      • 3.3.2. Dermatology and Cosmetic Clinics
      • 3.3.3. Ambulatory Surgical Centers
    • 3.4. Global Injection Lipolysis Market Outlook, by Region, Value (US$ Bn), 2020-2033
      • 3.4.1. North America
      • 3.4.2. Europe
      • 3.4.3. Asia Pacific
      • 3.4.4. Latin America
      • 3.4.5. Middle East & Africa

    4. North America Injection Lipolysis Market Outlook, 2020-2033

    • 4.1. North America Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
      • 4.1.1. Deoxycholic Acid
      • 4.1.2. Phosphatidylcholine
      • 4.1.3. Others
    • 4.2. North America Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
      • 4.2.1. Facial Fat Deposits
      • 4.2.2. Submental Fat
      • 4.2.3. Upper Arm Fat
      • 4.2.4. Abdominal Fat
      • 4.2.5. Thighs Fat
      • 4.2.6. Knee Fat
      • 4.2.7. Buttock Fat
      • 4.2.8. Others
    • 4.3. North America Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
      • 4.3.1. Hospitals
      • 4.3.2. Dermatology and Cosmetic Clinics
      • 4.3.3. Ambulatory Surgical Centers
    • 4.4. North America Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 4.4.1. U.S. Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 4.4.2. U.S. Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 4.4.3. U.S. Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 4.4.4. Canada Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 4.4.5. Canada Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 4.4.6. Canada Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 4.5. BPS Analysis/Market Attractiveness Analysis

    5. Europe Injection Lipolysis Market Outlook, 2020-2033

    • 5.1. Europe Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
      • 5.1.1. Deoxycholic Acid
      • 5.1.2. Phosphatidylcholine
      • 5.1.3. Others
    • 5.2. Europe Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
      • 5.2.1. Facial Fat Deposits
      • 5.2.2. Submental Fat
      • 5.2.3. Upper Arm Fat
      • 5.2.4. Abdominal Fat
      • 5.2.5. Thighs Fat
      • 5.2.6. Knee Fat
      • 5.2.7. Buttock Fat
      • 5.2.8. Others
    • 5.3. Europe Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
      • 5.3.1. Hospitals
      • 5.3.2. Dermatology and Cosmetic Clinics
      • 5.3.3. Ambulatory Surgical Centers
    • 5.4. Europe Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 5.4.1. Germany Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 5.4.2. Germany Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 5.4.3. Germany Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 5.4.4. Italy Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 5.4.5. Italy Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 5.4.6. Italy Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 5.4.7. France Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 5.4.8. France Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 5.4.9. France Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 5.4.10. U.K. Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 5.4.11. U.K. Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 5.4.12. U.K. Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 5.4.13. Spain Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 5.4.14. Spain Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 5.4.15. Spain Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 5.4.16. Russia Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 5.4.17. Russia Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 5.4.18. Russia Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 5.4.19. Rest of Europe Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 5.4.20. Rest of Europe Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 5.4.21. Rest of Europe Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.5. BPS Analysis/Market Attractiveness Analysis

    6. Asia Pacific Injection Lipolysis Market Outlook, 2020-2033

    • 6.1. Asia Pacific Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
      • 6.1.1. Deoxycholic Acid
      • 6.1.2. Phosphatidylcholine
      • 6.1.3. Others
    • 6.2. Asia Pacific Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
      • 6.2.1. Facial Fat Deposits
      • 6.2.2. Submental Fat
      • 6.2.3. Upper Arm Fat
      • 6.2.4. Abdominal Fat
      • 6.2.5. Thighs Fat
      • 6.2.6. Knee Fat
      • 6.2.7. Buttock Fat
      • 6.2.8. Others
    • 6.3. Asia Pacific Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
      • 6.3.1. Hospitals
      • 6.3.2. Dermatology and Cosmetic Clinics
      • 6.3.3. Ambulatory Surgical Centers
    • 6.4. Asia Pacific Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 6.4.1. China Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 6.4.2. China Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 6.4.3. China Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 6.4.4. Japan Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 6.4.5. Japan Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 6.4.6. Japan Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 6.4.7. South Korea Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 6.4.8. South Korea Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 6.4.9. South Korea Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 6.4.10. India Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 6.4.11. India Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 6.4.12. India Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 6.4.13. Southeast Asia Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 6.4.14. Southeast Asia Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 6.4.15. Southeast Asia Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 6.4.16. Rest of SAO Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 6.4.17. Rest of SAO Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 6.4.18. Rest of SAO Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.5. BPS Analysis/Market Attractiveness Analysis

    7. Latin America Injection Lipolysis Market Outlook, 2020-2033

    • 7.1. Latin America Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
      • 7.1.1. Deoxycholic Acid
      • 7.1.2. Phosphatidylcholine
      • 7.1.3. Others
    • 7.2. Latin America Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
      • 7.2.1. Facial Fat Deposits
      • 7.2.2. Submental Fat
      • 7.2.3. Upper Arm Fat
      • 7.2.4. Abdominal Fat
      • 7.2.5. Thighs Fat
      • 7.2.6. Knee Fat
      • 7.2.7. Buttock Fat
      • 7.2.8. Others
    • 7.3. Latin America Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
      • 7.3.1. Hospitals
      • 7.3.2. Dermatology and Cosmetic Clinics
      • 7.3.3. Ambulatory Surgical Centers
    • 7.4. Latin America Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 7.4.1. Brazil Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 7.4.2. Brazil Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 7.4.3. Brazil Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 7.4.4. Mexico Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 7.4.5. Mexico Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 7.4.6. Mexico Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 7.4.7. Argentina Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 7.4.8. Argentina Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 7.4.9. Argentina Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 7.4.10. Rest of LATAM Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 7.4.11. Rest of LATAM Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 7.4.12. Rest of LATAM Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 7.5. BPS Analysis/Market Attractiveness Analysis

    8. Middle East & Africa Injection Lipolysis Market Outlook, 2020-2033

    • 8.1. Middle East & Africa Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
      • 8.1.1. Deoxycholic Acid
      • 8.1.2. Phosphatidylcholine
      • 8.1.3. Others
    • 8.2. Middle East & Africa Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
      • 8.2.1. Facial Fat Deposits
      • 8.2.2. Submental Fat
      • 8.2.3. Upper Arm Fat
      • 8.2.4. Abdominal Fat
      • 8.2.5. Thighs Fat
      • 8.2.6. Knee Fat
      • 8.2.7. Buttock Fat
      • 8.2.8. Others
    • 8.3. Middle East & Africa Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
      • 8.3.1. Hospitals
      • 8.3.2. Dermatology and Cosmetic Clinics
      • 8.3.3. Ambulatory Surgical Centers
    • 8.4. Middle East & Africa Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
      • 8.4.1. GCC Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 8.4.2. GCC Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 8.4.3. GCC Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 8.4.4. South Africa Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 8.4.5. South Africa Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 8.4.6. South Africa Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 8.4.7. Egypt Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 8.4.8. Egypt Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 8.4.9. Egypt Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 8.4.10. Nigeria Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 8.4.11. Nigeria Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 8.4.12. Nigeria Injection Lipolysis Market Outlook, by End-user, 2020-2033
      • 8.4.13. Rest of Middle East Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
      • 8.4.14. Rest of Middle East Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
      • 8.4.15. Rest of Middle East Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.5. BPS Analysis/Market Attractiveness Analysis

    9. Competitive Landscape

    • 9.1. Company Vs Segment Heatmap
    • 9.2. Company Market Share Analysis, 2025
    • 9.3. Competitive Dashboard
    • 9.4. Company Profiles
      • 9.4.1. Allergan (AbbVie)
        • 9.4.1.1. Company Overview
        • 9.4.1.2. Product Portfolio
        • 9.4.1.3. Financial Overview
        • 9.4.1.4. Business Strategies and Developments
      • 9.4.2. Cynosure (Hologic)
      • 9.4.3. Galderma
      • 9.4.4. Merz Aesthetics
      • 9.4.5. SBC Aesthetic
      • 9.4.6. Suneva Medical
      • 9.4.7. Dermatech Corporation
      • 9.4.8. Teoxane Laboratories
      • 9.4.9. Biotech Pharma Group
      • 9.4.10. Sculpture Aesthetic

    10. Appendix

    • 10.1. Research Methodology
    • 10.2. Report Assumptions
    • 10.3. Acronyms and Abbreviations
    • 샘플 요청 목록
    0 건의 상품을 선택 중
    목록 보기
    전체삭제